– NewAmsterdam to host conference call at 10:00 a.m. ET on Wednesday, July 30th –NAARDEN, the Netherlands and MIAMI, July…
—Top 4% of Global Applicants Selected to Compete for $800K in Non-Dilutive Funding and Unmatched Industry Access— —Up to 13…
Comprehensive review of broad pipeline targeting Alzheimer’s disease agitation, depression, narcolepsy, fibromyalgia, ADHD, and smoking cessation, with new data analyses…
Expanded Executive Team Brings Deep Expertise in Care Delivery, Operations, and Product Development to Support Expansion AUSTIN, Texas, July 17,…
Physicians believe AI could speed up clinical trial matching and enrollment, increasing patient access to relevant emerging treatments, according to…
Life sciences teams can discover and assess Century Health's extensive longitudinal data without accessing or revealing underlying dataCentury Health's AI…
Additional world-leading expertise stands to further accelerate the Company’s pipeline programs targeting rare neurodegenerative diseasesOXFORD, United Kingdom, July 16, 2025…
Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for…
OpenEvidence also announces the wide release of OpenEvidence DeepConsult™—the first AI agent purpose-built for physicians CAMBRIDGE, Mass., July 15, 2025…
Kester Capital-backed Evestia Clinical merges with US-based Atlantic Research Group (ARG) to create a leading independent global specialist CRO in…